Tofersen, now known as Qalsody, targets a particular genetic gene, SOD1, which is present in 2 % of asymptomatic ALS ( Amyotrophic lateral sclerosis ). In some patients, it has been shown that this medication slows and yet reverses the development of symptoms.

Major stabilization of symptoms was demonstrated in a recent randomized, controlled clinical trial among participants who received tofersen.

More than 20 % of these patients underwent a three-year improvement in body strength and work, which is a not uncommon result in the framework of ALS therapy.

The study's lead author, Dr. Timothy Miller, the lead author of the study and David Clayson Professor of Neurology at Washington University School of Medicine in St. Louis, told ABC News that these studies may represent a significant step toward finding solutions that address the underlying biological causes of ALS.

" This is our first study to demonstrate incredibly serious restoration and slowing. " According to him," I believe this research demonstrates that some Und conditions are treatable. "

Neurological disorders that control deliberate body movement and breathing are caused by the condition ALS.

Patient comments

Jessica Morris ' quality of life has significantly improved since she started using Tofersen and had access to more resources. She now has some flexibility and is able to perform daily tasks after becoming afflicted with muscle weakness and wheelchair dependence.

" This medicine gives me hope, the trust of a coming I never dreamed of having," Morris said to ABC News.

" It's like winning the lottery to have Und and the chance to receive a drug that, in my case, helped me get out of the chair. "

“That’s very important,” he explained.

A bright potential awaits.

The benefits of the clinical trial and the stories of people like Morris offer a ray of hope as the number of ALS cases continues to rise.

Although the profit is limited to a small percentage of patients, experts believe this medicine was revolutionize ALS therapy and improve the quality of life for many.

You might also be interested in:

This news has been tken from authentic news syndicates and agencies and only the wordings has been changed keeping the menaing intact. We have not done personal research yet and do not guarantee the complete genuinity and request you to verify from other sources too.